T. Rowe Price Investment Management, Inc.
Position in LLY — ELI LILLY & Co
CIK 1897612
BALTIMORE, MD
Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$60,549,630
-$883,645,782 QoQ
Shares Held
50,482
-95.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#505
of 4,626 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026T. Rowe Price Investment Management, Inc. holds $130,347,685 across 8 Drug Manufacturers - General names. LLY ranks #1 (46.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
50,482 | $60,549,630 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
276,379 | $34,917,722 | |
| 3 | BIIB |
Biogen Inc.
|
113,873 | $24,603,400 | |
| 4 | JNJ |
Johnson & Johnson
|
19,637 | $4,987,208 | |
| 5 | ABBV |
AbbVie Inc.
|
5,805 | $1,460,770 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
24,400 | $1,405,928 | |
| 7 | PFE |
Pfizer Inc
|
56,140 | $1,351,851 | |
| 8 | MRK |
Merck & Co., Inc.
|
8,336 | $1,071,176 |
All Filings in LLY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,549,630 | 50,482 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $944,195,412 | 1,026,556 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $840,223,590 | 781,836 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $835,253,048 | 1,094,696 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $780,338,372 | 1,001,037 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $921,200,192 | 1,115,376 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $610,480,616 | 790,778 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $687,357,434 | 775,851 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $895,673,421 | 989,279 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $863,250,866 | 1,109,634 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $648,247,261 | 1,112,069 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $701,703,946 | 1,306,395 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $615,817,169 | 1,313,099 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $455,498,207 | 1,326,359 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $445,943,960 | 1,218,959 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||